Clinical Trials Browser

Phase 2 × Neoplasms × Cell- and Tissue-Based Therapy × Clear all

NCT00149006 2007-03-14

Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With Recombinant Interleukin-2 (rIL-2) for Metastatic Solid Tumors

Phase 2 Unknown

Neoplasm Metastasis, Neoplasms